We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current MTAC market cap is 22.15M. The company's latest EPS is USD -32.3999 and P/E is -0.35.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Revenue | 12.79M | 5.72M | 6.46M | 7.36M | 7.35M |
Operating Income | -37.76M | -14.12M | -11.69M | -8.17M | -8.73M |
Net Income | -25.53M | -36.31M | -14.02M | -5.13M | -3.19M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 18.51M |
Operating Income | -108k | -3.04M | -2.75M | -54.15M |
Net Income | -105k | 4.77M | 5.54M | -63.28M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Assets | 33.55M | 25.73M | 17.89M | 32.43M | 27.48M |
Total Liabilities | 25.07M | 51.66M | 52.81M | 56.58M | 47.91M |
Total Equity | 8.49M | -25.94M | -34.92M | -24.15M | -20.43M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 252.01M | 250.53M | 20.19M | 25.73M |
Total Liabilities | 8.85M | 17.25M | 13.66M | 51.66M |
Total Equity | 5M | -16.72M | -13.27M | -25.94M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Operating | -41.2M | -50.05M | -10.87M | -24.29M | -35.14M |
Investing | -1.42M | -2.12M | -66k | -126k | -295k |
Financing | 54.59M | 54.63M | 3.13M | 29.12M | 34.94M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -678k | -1.74M | -2.74M | -50.05M |
Investing | -250M | 60k | 233.2M | -2.12M |
Financing | 252.01M | 544k | -230.51M | 54.63M |
Market Cap | 22.15M |
Price to Earnings Ratio | -0.35 |
Price to Sales Ratio | 1.2 |
Price to Cash Ratio | 1.88 |
Price to Book Ratio | -0.85 |
Dividend Yield | - |
Shares Outstanding | 1.95M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.64 (5.36%) |
Company Name | MedTech Acquisition Corporation |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https:// |
Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions